Best Full Spectrum CBD Gummies: Top 5 Products Reviewed
The CBD landscape has evolved far beyond oils and tinctures. Today, full spectrum CBD gummies offer a delicious way to experience the natural benefits of the hemp plant — including its rich mix of …
“Trump effect” sparks new bets on US cannabis retail
might cover CBD products. That signal, even without formal policy, helped reignite bets on cannabis retail. Although the claim was not verified by any government agency, the post sent cannabis stocks …
CBD Life Sciences Inc. (OTC: CBDL) Launches Tremendous Energy & Weight-Loss Diet Hemp-Free Gummies
Detailed price information for Cbd Life Sciences Inc (CBDL) from The Globe and Mail including charting and trades.
Avecho’s CBD Study: A Potential Game-Changer for Insomnia Treatment
Avecho Biotechnology Limited (($AU:AVE)) announced an update on their ongoing clinical study. Study Overview: Avecho Biotechnology Limited is …
Innocan Pharma to Showcase Innovative Pain Management Platform at 2025 ThinkEquity Conference
An announcement from InnoCan Pharma ( ($TSE:INNO) ) is now available. Innocan Pharma announced its participation in the 2025 ThinkEquity …
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
CBD Life Sciences Inc. (CBDL) Secures Major Hemp Flower Order From Bronx Dispensary Smoking Scholars Amid Explosive Growth
Detailed price information for Cbd Life Sciences Inc (CBDL) from The Globe and Mail including charting and trades.
The Hemp War
You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers stay …
Aurora Cannabis Lifts Outlook As CEO Hails Record Medical Marijuana Growth In Q2
Looking ahead, Aurora expects its third-quarter 2026 consolidated revenue to increase year over year, led by 8% to 12% growth in global medical cannabis sales. Management also projects continued …
Vornado price target lowered to $38 from $39 at Piper Sandler
Piper Sandler lowered the firm’s price target on Vornado (VNO) to $38 from $39 and keeps a Neutral rating on the shares. The firm notes the …
Trump’s CBD Medicare signal sparks 36% boost in cannabis stocks — but should investors hold or brace for policy risks?
Cannabis investors recently saw a jolt of optimism after President Donald Trump signaled support for covering CBD oil under Medicare. With the news, stock prices soared. A few of the companies that …
Tilray Brands (TLRY) Climbs 8% Ahead of Cannabis, CBD Policy Decision
We recently published 10 Hot Stocks Sparking Buying Frenzy. Tilray Brands Inc. (NASDAQ:TLRY) is one of the best performers on Tuesday. Tilray Brands Inc. (NASDAQ:TLRY) grew its share prices by 8.23 …
Cannabis stocks are on a roll: Here’s how to play the surge
Cannabis stocks are in focus after President Trump said CBD could “revolutionize senior healthcare” in a Truth Social post. The comment sent bullish signals through the cannabis space, coming months …
CBD Edibles Market Size to Exceed USD 38.01 Billion by 2034, Driven by 10.8% CAGR | Towards FnB
According to Towards FnB, the global CBD edibles market size is calculated at USD 15.10 billion in 2025 and is forecasted to hit USD 38.01 billion by 2034. This represents a compound annual growth …
Aurora Cannabis (TSX:ACB): Exploring Valuation After U.S. Signals Possible Shift in CBD and Marijuana Policy
Aurora Cannabis (TSX:ACB) shares jumped following President Donald Trump’s endorsement of cannabidiol, or CBD, as an alternative in senior healthcare, along with growing speculation about changes to U …
Recent Comments